Abstract
Phase I–II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have